Skip to content

The feasibility study of a new model of phase II cardiac rehabilitation in patients with coronary heart disease after PCI

The feasibility study of a new model of phase II cardiac rehabilitation in patients with coronary heart disease after PCI

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100049454
Enrollment
Unknown
Registered
2021-08-02
Start date
2021-11-01
Completion date
Unknown
Last updated
2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Heart Disease

Interventions

Experimental group:Aerobic exercise + conventional medication

Sponsors

The Second Affiliated Hospital of Shandong First Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 74 Years

Inclusion criteria

Inclusion criteria: 1. Male and female patients aged 35 to 74 years; 2. Coronary heart disease is diagnosed by coronary angiography and one month after coronary stent implantation; 3. The cardiac function classification is I-II (NYHA classification); 4. Able to cooperate with oral medication, rehabilitation treatment and follow-up; 5. Have normal intelligence and be able to exercise independently; 6. The subject understands the content and procedure of the experiment, and agrees to accept the experiment at the same time.

Exclusion criteria

Exclusion criteria: 1. Acute myocardial infarction within 3-5 days; 2. Unstable angina pectoris; 3. Malignant arrhythmia that causes hemodynamic instability; 4. Severe symptoms of aortic stenosis or other valvular diseases; 5. Heart failure decompensation period; 6. Acute pulmonary embolism or pulmonary infarction; 7. Acute non-cardiac diseases that affect the completion of exercise or exercise can make it worse (for example, infection, hyperthyroidism); 8. Acute myocarditis or pericarditis; 9. Acute thrombophlebitis; 10. Disability hinders safe and accurate testing.

Design outcomes

Primary

MeasureTime frame
Cardiopulmonary exercise test;left ventricular ejection fraction;Electrocardiogram;

Secondary

MeasureTime frame
Blood cell analysis;liver function;Kidney function;

Countries

China

Contacts

Public ContactLi Yuanmin

The Second Affiliated Hospital of Shandong First Medical University

liym575@126.com+86 13583843518

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026